Cargando…

ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer

ABIN-1, also called TNIP1, is an ubiquitin-binding protein that serves an important role in suppressing RIPK1-independent apoptosis, necroptosis, and NF-κB activation. However, the involvement of ABIN-1 in the regulation of RIPK1-dependent apoptosis (RDA) is unknown. In this study, we found that pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jiali, Hu, Die, Sakya, Judy, Sun, Tao, Wang, Daoyong, Wang, Lin, Mao, Xiaohua, Su, Zhenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862295/
https://www.ncbi.nlm.nih.gov/pubmed/33542218
http://dx.doi.org/10.1038/s41419-021-03427-y
_version_ 1783647258603945984
author Cai, Jiali
Hu, Die
Sakya, Judy
Sun, Tao
Wang, Daoyong
Wang, Lin
Mao, Xiaohua
Su, Zhenyi
author_facet Cai, Jiali
Hu, Die
Sakya, Judy
Sun, Tao
Wang, Daoyong
Wang, Lin
Mao, Xiaohua
Su, Zhenyi
author_sort Cai, Jiali
collection PubMed
description ABIN-1, also called TNIP1, is an ubiquitin-binding protein that serves an important role in suppressing RIPK1-independent apoptosis, necroptosis, and NF-κB activation. However, the involvement of ABIN-1 in the regulation of RIPK1-dependent apoptosis (RDA) is unknown. In this study, we found that poly(I:C) + TAK1 inhibitor 5Z-7-oxozeaenol (P5) concurrently induces RDA and necroptosis in Abin-1(−/−), but not in Abin-1(+/+) mouse embryonic fibroblasts (MEFs). Upon P5 stimulation, cells initially die by necroptosis and subsequently by RDA. Furthermore, we explored the therapeutic effect of ABIN-1 deficiency in necroptosis-based cancer therapy in colorectal cancer (CRC). We found that poly(I:C) + 5Z-7-oxozeaenol + IDN-6556 (P5I) yields a robust pro-necroptosis response, and ABIN-1 deficiency additionally enhances this P5I-induced necroptosis. Moreover, phase I/II cIAP inhibitor birinapant with clinical caspase inhibitor IDN-6556 (BI) alone and 5-fluorouracil with IDN-6556 (FI) alone are sufficient to induce necroptotic cell death in CRC cells by promoting auto-secretion of tumor necrosis factor (TNF); ABIN-1 deficiency amplifies the BI- or FI-induced necroptosis. Two independent xenograft experiments using HT-29 or COLO205 cells show that both BI and P5I remarkably inhibit tumor growth via necroptosis activation. For poly(I:C)-induced cell death, the sensitizing effect of ABIN-1 deficiency on cell death may be attributed to increased expression of TLR3. In TNF-induced necroptosis, ABIN-1 deficiency increases TNF-induced RIPK1 polyubiquitination by reducing the recruitment of ubiquitin-editing enzyme A20 to the TNFR1 signaling complex and induces more TNF secretion in CRC cells upon pro-necroptosis stimulation. With this combined data, ABIN-1 deficiency promotes greater sensitization of CRC cells to necroptosis.
format Online
Article
Text
id pubmed-7862295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78622952021-02-16 ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer Cai, Jiali Hu, Die Sakya, Judy Sun, Tao Wang, Daoyong Wang, Lin Mao, Xiaohua Su, Zhenyi Cell Death Dis Article ABIN-1, also called TNIP1, is an ubiquitin-binding protein that serves an important role in suppressing RIPK1-independent apoptosis, necroptosis, and NF-κB activation. However, the involvement of ABIN-1 in the regulation of RIPK1-dependent apoptosis (RDA) is unknown. In this study, we found that poly(I:C) + TAK1 inhibitor 5Z-7-oxozeaenol (P5) concurrently induces RDA and necroptosis in Abin-1(−/−), but not in Abin-1(+/+) mouse embryonic fibroblasts (MEFs). Upon P5 stimulation, cells initially die by necroptosis and subsequently by RDA. Furthermore, we explored the therapeutic effect of ABIN-1 deficiency in necroptosis-based cancer therapy in colorectal cancer (CRC). We found that poly(I:C) + 5Z-7-oxozeaenol + IDN-6556 (P5I) yields a robust pro-necroptosis response, and ABIN-1 deficiency additionally enhances this P5I-induced necroptosis. Moreover, phase I/II cIAP inhibitor birinapant with clinical caspase inhibitor IDN-6556 (BI) alone and 5-fluorouracil with IDN-6556 (FI) alone are sufficient to induce necroptotic cell death in CRC cells by promoting auto-secretion of tumor necrosis factor (TNF); ABIN-1 deficiency amplifies the BI- or FI-induced necroptosis. Two independent xenograft experiments using HT-29 or COLO205 cells show that both BI and P5I remarkably inhibit tumor growth via necroptosis activation. For poly(I:C)-induced cell death, the sensitizing effect of ABIN-1 deficiency on cell death may be attributed to increased expression of TLR3. In TNF-induced necroptosis, ABIN-1 deficiency increases TNF-induced RIPK1 polyubiquitination by reducing the recruitment of ubiquitin-editing enzyme A20 to the TNFR1 signaling complex and induces more TNF secretion in CRC cells upon pro-necroptosis stimulation. With this combined data, ABIN-1 deficiency promotes greater sensitization of CRC cells to necroptosis. Nature Publishing Group UK 2021-02-01 /pmc/articles/PMC7862295/ /pubmed/33542218 http://dx.doi.org/10.1038/s41419-021-03427-y Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Cai, Jiali
Hu, Die
Sakya, Judy
Sun, Tao
Wang, Daoyong
Wang, Lin
Mao, Xiaohua
Su, Zhenyi
ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_full ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_fullStr ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_full_unstemmed ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_short ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_sort abin-1 is a key regulator in ripk1-dependent apoptosis (rda) and necroptosis, and abin-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862295/
https://www.ncbi.nlm.nih.gov/pubmed/33542218
http://dx.doi.org/10.1038/s41419-021-03427-y
work_keys_str_mv AT caijiali abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT hudie abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT sakyajudy abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT suntao abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT wangdaoyong abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT wanglin abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT maoxiaohua abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT suzhenyi abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer